Projects per year
Personal profile
Research Statement
The Stratified Medicine Group focuses on the following areas:
1) Characterisation of a molecular group in solid cancers that represents an innate immune response to DNA damage through the STING pathway.
2) Development of a biomarker for anti-angiogenic agents
3) Development of a biomarker for MEKK pathway activation
4) Identification of a prognostic biomarker for early prostate cancer
5) Development of new cell lines for pre-clinical modelling of ovarian and prostate cancer.
Other
Linked in Profile:
https://www.linkedin.com/in/profkennedy/
Expertise related to UN Sustainable Devlopment Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Richard Kennedy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
R1005PMY: Artificial Intelligence Enables Clinical Decision Making in the Digital Healthcare Era
McArt, D., Kennedy, R. & Salto-Tellez, M.
12/02/2019 → …
Project: Research
-
R3005CNR: Establishing a Precision Medicine Catapult Centre of Excellence in Northern Ireland
Salto-Tellez, M., Gonzalez de Castro, D., James, J., Kennedy, R., McArt, D. & Waugh, D.
01/12/2017 → …
Project: Research
-
R1523CNR: “S-CORT: Stratification in COloRectal cancer: from biology to Treatment prediction”.
Lawler, M., Johnston, P., Kennedy, R., Salto-Tellez, M. & Wilson, R.
29/04/2015 → …
Project: Research
-
R6416CNR: Phase 1B/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients
Van Schaeybroeck, S., Johnston, P., Kennedy, R., Lawler, M., Longley, D., Salto-Tellez, M. & Wilson, R.
01/08/2013 → …
Project: Research
-
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer
Malla, S. B., Fisher, D. J., Domingo, E., Blake, A., Hassanieh, S., Redmond, K. L., Richman, S. D., Youdell, M., Walker, S. M., Logan, G. E., Chatzipli, A., Amirkhah, R., Humphries, M. P., Craig, S. G., McDermott, U., Seymour, M. T., Morton, D. G., Quirke, P., West, N. P., Salto-Tellez, M. & 12 others, , 01 Jan 2021, In: Clinical Cancer Research. 27, 1, p. 288-300Research output: Contribution to journal › Article › peer-review
-
Robustness of differential gene expression analysis of RNA-seq
Stupnikov, A., McInerney, C. E., Savage, K. I., McIntosh, S. A., Emmert-Streib, F., Kennedy, R., Salto-Tellez, M., Prise, K. M. & McArt, D. G., 26 May 2021, In: Computational and Structural Biotechnology Journal. 19, p. 3470-3481 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile8 Downloads (Pure) -
The clinical and molecular significance associated with STING signaling in breast cancer
Parkes, E. E., Humphries, M. P., Gilmore, E., Sidi, F. A., Bingham, V., Phyu, S. M., Craig, S., Graham, C., Miller, J., Griffin, D., Salto-Tellez, M., Madden, S., Kennedy, R. D., Bakhoum, S. F., McQuaid, S. & Buckley, N. E., 25 Jun 2021, In: npj Breast Cancer. 7, 11 p., 81.Research output: Contribution to journal › Article › peer-review
Open AccessFile5 Downloads (Pure) -
Abstract P1-10-17: cGAS-STING driven immune activation predicts response to neoadjuvant chemotherapy and suggests rational IO combination therapies: Results of the Neo-DDIR study
McIntosh, S. A., Savage, K. I., James, C., Lioe, T., Walker, S., Lowry, K., Knight, L., McGavigan, A., Logan, G., Hurwitz, J., Kirk, S. J., Harkin, P., Kennedy, R. D. & Parkes, E. E., 14 Feb 2020, In: Cancer Res. 80, 4 Supplement, P1-10-17.Research output: Contribution to journal › Meeting abstract › peer-review
-
ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising Radiation
Hanna, C., Dunne, V. L., Walker, S. M., Butterworth, K. T., McCabe, N., Waugh, D. J. J., Kennedy, R. D. & Prise, K. M., 30 Dec 2020, In: Cancers. 13, 1Research output: Contribution to journal › Article › peer-review
Open AccessFile10 Downloads (Pure)
Prizes
-
Queen’s University of Belfast Vice Chancellor Award for Innovation
Kennedy, Richard (Recipient), 2013
Prize: Prize (including medals and awards)
-
St Luke’s Medal for Cancer Research. Royal College of Medicine, Ireland
Kennedy, Richard (Recipient), 2015
Prize: Prize (including medals and awards)
Press / Media
-
Targetable Immune Biology Found in Some Patients With Early-Stage Prostate Cancer
26/03/2018
1 Media contribution
Press/Media: Research
-
Behind the Science. 30 minute TV programme on Cancer Research at QUB/Almac
13/12/2017
1 Media contribution
Press/Media: Public Engagement Activities
-
High-tech disease profiling is the next stage in the fight against cancer
30/10/2017
1 Media contribution
Press/Media: Research
-
-
A visit to the Doctor in 2013. Public lecture.
10/10/2017
1 item of Media coverage
Press/Media: Public Engagement Activities
Impact
-
Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation
Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant) & Daniel Longley (Participant)
Impact: Health Impact, Quality of Life Impact